MARCOL Health invests in Medneo


Following the successful sale of Germany’s leading post-acute hospital provider Median Kliniken, MARCOL Health, a part of MARCOL, has announced its partnership and substantial investment in the Berlin based business ‘medneo’, an innovative diagnostic imaging operator solution.

MARCOL Health plans to provide the business with an international infrastructure and growth capital to both accelerate national expansion across Germany and enter new international markets.

medneo was founded in 2011, and specialises in “Radiology as a Service” with its own highly efficient operated diagnostic platforms and an international tele-radiology network. medneo offers its customers (physicians, hospitals, research institutes) fully equipped diagnostic imaging platforms (mostly MRI and CT) including the entire non-medical operation and management of the diagnostic value-chain with the result of cost reduction and quality increase. Customers buy clinical images instead of medical equipment.

The plan for medneo is to continue with its successful roll-out across Germany – in the out- and inpatient sector – strengthening its market position with the “shared economy concept” in the diagnostic imaging market. The international expansion will be accompanied by a continuous development of new products and services which will enable a highly innovative way to efficiently operate diagnostic imaging platforms for customers around the globe – whilst proving worldwide services and quality of the highest German standard.

Over the next few years, the business aims to establish many diagnostic imaging platforms across the globe, delivering a substantial number of scans to customers world wide.

Nicholas Weber, one of medneo’s joint CEOs representing the medneo team commented “we are very happy to join forces with our new partner MARCOL Health, not only will they provide us with important growth capital but their international experience in building global healthcare businesses will definitely accelerate our international strategy”.

In response, Ed Radkiewicz MARCOL Health’s Managing Director said “it’s rare that you find the combination of an excellent team with outstanding expertise and a proven innovative business model that is scalable with global potential, we are very excited indeed!”

More news >

Recent posts

Terence Cole, our Co-Founder and Joint CEO of MARCOL, sadly passed away on Monday 19 December 2022, after a long illness.

Terence was a larger-than-life character who has left his mark on the world and touched many lives. He was tenacious, a great strategic thinker, …

MARCOL Executive Forum

We recently held our annual MARCOL Executive Forum, bringing together our senior team, and the CEOs and leadership of the MARCOL Portfolio companies: ALMCOR, Atida, …

Creating scalable Healthtech platforms to improve patient access

Published in the 'Global Family Office Community' Journal Article by Ed Radkiewicz, CEO - MARCOL Health   Creating scalable Healthtech platforms to improve …

Thames Enterprise Park wins planning permission for initial 3.7 million sq ft development

Regeneration of former Coryton oil refinery site will create 5,500 new jobs and expected to add £350 million per year to the local economy. Thames …

iSec evolves with new strategy and rebrand as ALMCOR

PRESS RELEASE CEO Jonathan Whittingham looking to widen from industrials into retail, strategic land and first mile logistics as part of diversification and growth Leading …

GoodShape & MARCOL Health innovating in the employee and wellbeing sector

Advertorial in HealthInvestor Publication Innovating in the employee and wellbeing sector Businesses around the world have long struggled to control the impact of employee absence …